Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
Blog
Page 4
Blog
Blog
Are EUAs Deregulation or Regulatory Capture? Why Emergency Use Authorizations Should Stay
Raymond March
-
April 21, 2022
0
Blog
FDA Continues to Meddle with Covid-19 Treatments
Raymond March
-
February 10, 2022
0
Blog
The Covid-19 Ratchet Effect is Becoming Clearer, and More Concerning
Raymond March
-
July 2, 2021
0
Blog
Will the Biden Administration Let a Delta-Variant Covid-19 Crisis Go to Waste?
Raymond March
-
July 1, 2021
0
Blog
New Alzheimer’s Drug Approval Could Change the FDA’s Approval Process for the Better
Raymond March
-
June 10, 2021
0
Blog
Ecstasy Nears FDA Approval to Treat Severe Post-Traumatic Stress Disorder
Raymond March
-
June 3, 2021
0
Blog
AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions
Raymond March
-
March 26, 2021
0
Blog
Are We Witnessing the Beginning of the Covid-19 Ratchet Effect?
Raymond March
-
March 22, 2021
0
Blog
The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug
Raymond March
-
March 3, 2021
0
Blog
President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He Succeed?
Raymond March
-
February 10, 2021
0
1
...
3
4
5
...
13
Page 4 of 13
